Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-06

FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Topamax (topiramate) submitted by Janssen Pharmaceuticals, updating the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

SUPPL AP for TOPAMAX (TOPIRAMATE)